We have established a highly sensitive and specific exon-trapping system (SETS) with a specific plasmid vector in which an exon in a given DNA segment is identified by its ability to remain as a mature mRNA after splicing. The SETS provides us with the isolation of possible exons rapidly and easily from DNA fragments in chromosomal regions of more than 300 kilobase pairs. Genomic DNA fragments were partially digested and subsequently cloned into plasmid pMHC2, an exon-trapping vector we have constructed. These constructs were transfected into COS-7 cells, and consequent RNA transcripts were spliced in the cells. The resulting mature mRNA was harvested and amplified by using reverse transcription-PCR. Possible exons can be recognized by the sizes of PCR products and cloned into a plasmid vector. The SETS provides a direct means of cloning exons from genomic DNA of more than 300 kilobase pairs within a short period of time. Using this system, we have screened 300-kilobase-pair genomic DNA segments derived from human chromosome 11q13. Human chromosome 11q13 may contain genes responsible for human cancers, because DNA amplification is observed in several malignant tumors. We have successfully identified exon 2 of the HSTI gene and additional transcribed sequences.
Detailed genetic and physical maps for human chromosomes have been constructed to determine the chromosomal locations of the genes responsible for many human genetic disorders and cancers. The minimal region in which a gene of interest can be found spans several hundred kilobase pairs. Identification and recovery of transcribed sequences from the region of interest are necessary to isolate candidate genes. This strategy has been successful in isolating a number of candidate genes, including Wilms tumor (1-3), neurofibromatosis type 1 (4, 5) , and familial adenomatous polyposis (6, 7) .
However, available methods for isolation of transcribed sequences from given DNA fragments are inefficient. Those methods most frequently used are interspecies crosshybridization to search for evolutionarily conserved sequences (3, 8) . Other methods include search for open reading frames (9) , enhancers (10), promoters (11, 12) , or hypomethylated CpG islands (13) . But none of these strategies involves direct cloning of transcribed sequences.
Alternative strategies to isolate transcribed sequences involve direct cloning of human transcripts from human-rodent somatic cell hybrids (14, 15) . These strategies, however, also have limitations. Possible transcripts derived from human DNA fragments might not be expressed sufficiently enough to be detected in hybrid cells. It is also not easy to establish those hybrid cell lines that contain only the target human DNA fragments.
Two exon-trapping systems based on RNA splicing have been reported and could be important tools for direct cloning of transcribed sequences. However, both of the exontrapping systems reported previously have disadvantages as described below. A strategy using the retroviral shuttle vector system described by Duyk et al. (16) takes much time to complete a round of screening, and the procedure is complicated. The other system, described by Buckler et al. (17) , worked efficiently; however, its usefulness for identification of exons in a given DNA fragment was still limited because of the following points. First, it was demonstrated that no more than one phage or cosmid can be screened by their system in a single transfection, and no mention was made about the maximum length of the target DNA fragments. The sensitivity of their system would not allow us to apply it to screening for possible exons from a large DNA segment such as is carried in yeast artificial chromosomes (YACs). Second, the combination of vector splice sites and cryptic splice sites of inserts might cause unusual splicing and result in production of false-positive exons. It was reported that three false positives out of four possible exons were generated by Buckler's system. To improve the sensitivity and specificity, we checked genomic DNA sequences of introns and searched for a sequence suitable for a trapping cassette. Check points were the following: first, a pyrimidine tract should be long enough to prevent exon skipping (18) . Second, consensus sequences at branch and splice sites should be best fitted to those of small nuclear RNAs involved in splicing. Third, the length of the intron should be longer than 500 base pairs (bp), because a short intron in the trapping cassette makes it difficult to distinguish spliced fragments from unspliced fragments and because most exons are shorter than 500 bp (19) . We found suitable sequences for the trapping cassette and have constructed an exon-trapping
vector. Here we demonstrate establishment ofa sensitive and specific exon-trapping system (SETS) both sensitive and specific enough to carry out large-scale screening of genomic DNA segments for the presence of exons, using this vector. We tested the SETS by isolation of transcribed sequences in overlapping cosmid clones corresponding to human chromosome 11q13 containing INT2 and HSTI (20) . We have successfully isolated three novel transcribed sequences from the region by this strategy, demonstrating the usefulness of this system, which is a powerful tool for simple screening of megabase genomic DNA segments for the presence of possible exons.
Proc. Nati. Acad. Sci. USA 89 (1992) ments for the trapping cassette. The primers (5'-CGT-GAAAQCTCGAGATGTTCCGA-3' and 5'-CAAGCTTC-TGACGCACATTTATTGCAAGCAA-3') were designed so that PCR products contain part ofexon 10, intron 10, and part of exon 11 of the p53 gene, with synthetic HindIII recognition sequence indicated by underlining. Genomic DNA ofan adult male was amplified by using these primers. PCR products were digested with HindIII and partially filled in with dATP and dGTP to produce a fragment of 1 kilobase (kb) with a 5' protruding AG sequence. The parent vector pEUK-C2 (Clontech) was cleaved at a unique Xba I restriction site, followed by partial fill-in with dCTP and dTTP to produce a 5' protruding sequence of CT. The PCR products were ligated with the vector to construct the pMHC2 vector (see Fig. 1 [3] , LP-2 [4] , and LP-4 [5] contain 30 -to 50-kbp genomic DNA segments derived from human chromosome 11q13 (22 (24) and purified with Bio-Spin 30 columns (Bio-Rad). Primary PCR amplification was performed between the forward primer 7rA (5'-TGAGGCCTTGGAACTCA-3') and the reverse primer irR (5'-GGAGAATGTCAGTCTGA-3') for 25 cycles. Thirty cycles of secondary PCR amplification were carried out between the forward primer irAB (5'-AGGGATCCCAGGC-TGGGAAGGA-3') and the reverse primer irRB (5'-ACGGAICCTTTTTGGACTTCAGGT-3') using 1/100th of the primary PCR products as a template. Both 1rAB and irRB primers contain a synthetic BamHI recognition sequence indicated by underlining. Positions of the primers are indicated in Fig. 1 .
Cloning of Trapped Fragments. The amplified DNA fragments were electrophoresed through polyacrylamide or 4% agarose gels, recovered from the gel (25) Genomic DNA digested with restriction endonucleases was electrophoresed through 1% agarose gels and transferred to Hybond N+ membranes (Amersham). To make probes, plasmid DNA with trapped fragments was linearized with BssHII and transcribed in the presence of 32P-labeled CTP with phage T3 or T7 RNA polymerases (23) . Hybridizations were carried out by standard procedures (23) .
Ribonuclease (RNase) Protection Assay. One microgram of pBluescript II SK+ was digested with BssHII, and labeled RNA probes were synthesized from the linearized plasmids as described above. The RNA probes were hybridized to 1 ,ug of poly(A)+ RNA from TE-1 cells at 450C for 16 hr. Unhybridized single-stranded RNA was digested with RNase A and RNase T1 (Ambion, Austin, TX). RNase digestion products were analyzed on denaturing polyacrylamide gels followed by autoradiography.
PCR Amplification of a cDNA Mixture from TE-1 Cells. A cDNA mixture derived from a AZAPII library of TE-1 cells containing about 1 million recombinant bacteriophages was amplified by PCR using primers 38A (5'-CATAAGTGC-CGATGGAGTAGGA-3'), 38R (5'-CTCTCCAATTTAGGA-TTCTCA), 40A (5'-TAGCTGACATTCAAAGCCTGGG-3'), and 40R (5'-CTGTGAGGACAGGAGCTGACAGA-3'). These primers were part of trapped fragments and were used for amplification of trapped fragments; 38A and 38R were for MB38 fragments. Primers 40A and 40R were for MB40 fragments (see Table 1 [5' -CAG/GTGAGT-3'], the 3' splice site (5'-AG-3'), and the branch site (5'-TACTCAC-3') ( Fig. 1) (26, 34, 35 ). The pMHC2 vector has a unique Bgl II site as a cloning site between the 5' splice site and the branch site (Fig. 1) . When an entire exon and the flanking intron derived from the test genomic DNA segments are inserted into the pMHC2 vector in the sense orientation, the transcripts from these plasmids are expected to be processed in the COS-7 cells after transfection, and exons can be identified by RT-PCR. Otherwise, RT-PCR products consist only of the exons of the p53 gene, and a single band of 72 bp is detected by ethidium bromide staining (Fig. 2) . Since amplified fragments longer than 72 bp in length contain possible exons and fragments longer than 1 kbp may contain unspliced transcripts, fragments between 90 bp and 900 bp were subcloned into pBluescript II SK+, sequenced, and analyzed for expression.
Trapping of the Known Exon with the SETS. As an initial examination of the system, derivatives of pMHC2 were constructed. pLBS6.2 plasmid, which carries a 6.2-kb DNA fragment including genomic sequences of the HSTJ gene from exon 1 to exon 3, was partially digested with Sau3AI, and fragments between 0.6 kbp and 5 kbp in length were vested. RT-PCR amplification was carried out, and the PCR products were separated through 4% agarose gels and analyzed by Southern blot analysis using 32P-labeled cDNA of the HSTI gene as a probe. As expected, the probe detected a single band of 160 bp (data not shown). A mixture of these cosmids was used for screening by the SETS. pMHC2/llql3 was constructed as follows: 250 ng each of the eight cosmid clones was partially digested with Sau3AI. DNA fragments from 0.6 kbp to 5 kbp were inserted into the pMHC2 vector. Ten micrograms of the plasmids was transfected to COS-7 cells, and all the procedures for exon trapping were carried out as described above. Several fragments >72 bp were detected by ethidium bromide staining ( Fig. 2A, lane 2) , whereas lane 3 contained only a single band of 72 bp. This demonstrates the successful amplification of possible exons. Electrophoresis through a 4.5% agarose gel demonstrated that only several bands can be visualized, indicating that random amplification did not occur (Fig. 2B) . Fragments amplified by RT-PCR were cloned into pBluescript II SK+, and thousands of transformed plasmid clones were obtained. The inserts of the plasmids are assorted into several groups (Fig. 3) , assuring that possible exons should be placed in one of several classifications. Sequence analysis of 35 clones revealed that these clones were assorted into eight independent groups. Seven groups contained exon 10 and exon 11 of the p53 gene with trapped fragments, and the other contained only the p53 gene. Seven trapped fragments were possible exons and examined further. One fragment was exon 2 of the HSTJ gene. To determine the derivation of the other possible exons, each fragment was hybridized with the cosmid panels (data not shown). All fragments originated from the cosmid clones on 11q13 (Table 1) .
Characterization of the Six Possible Exons. Interspecies cross-hybridization demonstrated that none of the possible exons except exon 2 of the HSTJ gene carries evolutionarily conserved sequences (data not shown). A screening of the GenBank data base (May 1992) showed no significant similarity among the sequences of these six possible exons and previously reported sequences. All trapped fragments were labeled by in vitro transcription and hybridized to poly(A)+ RNA of TE-1. The MB38 fragment detects transcripts of 2.7 kb and 1.9 kb, and the MB40 detects transcripts of 2.7 kb and 1 2 3 4 5 6 7 8 9 1.9 kb. MB42 detects transcripts of 5.2 kb, 3 kb, and 1.1 kb (Fig. 4A) . Ribonuclease protection assays demonstrated that the entire sequences of clones MB38, MB40, and MB42 should be exons (Fig. 4B) . PCR amplification of the cDNA mixture revealed that the cDNA library contains cDNA clones that are detectable by the MB38 and the MB40 fragments (Fig. 4C) . The MB15, MB22, and MB36 fragments did not hybridize to poly(A)+ RNA of TE-1.
DISCUSSION
The recent development of reverse genetics provides us with high-resolution maps and YAC libraries of a number of regions in which genes responsible for human diseases can be found. To identify the genes responsible for human diseases, construction of a detailed transcript map is indispensable. A transcript map should be made after subcloning YAC clones into cosmid vectors followed by identification of exons. This step to identify transcripts is essential. In addition, presently available methods for this purpose are inefficient. The exontrapping system has become an important technique for positional cloning (16, 17) . In spite of such successes, the applications of exon-trapping systems were restricted be- cause of their sensitivity and specificity. If a highly efficient system is established, it can be applied to a large-scale screening for transcribed sequences and provide a sophisticated approach to understanding the molecular basis of human diseases. Here we demonstrate the establishment of the SETS by using a pMHC2 vector that allows the exontrapping system to attain high sensitivity and strictness.
Strategies to isolate transcribed sequences directly have been reported. Human transcripts were isolated by screening cDNA libraries constructed from heterogeneous nuclear RNA ofhybrid cell lines for human repeat sequences (14, 15) . This approach would be generally applicable for cloning transcripts from any region of the human genome if an appropriate hybrid cell line were available. There are further limitations to this strategy. The number of possible exons isolated was much lower than that with the exon-trapping system. This is probably due to the following two reasons: first, not all immature transcripts have Alu repeats in their introns. Second, all human genes on the chromosomal segments contained in the hybrid cells would not be expressed as much as expected.
Alternative strategies based on RNA splicing have been reported, including a retrovirus system. One strategy using a retroviral shuttle vector system was tedious and inefficient (16) . Another exon-trapping system using a pSPL1 plasmid, which contains the human immunodeficiency virus 1 tat intron, demonstrated the recovery of an exon of the DNA excision repair gene ERCCI from a 20-kbp genomic DNA fragment with an incidence of false positives being 3 times higher than that of true exons (17) . Such sensitivity or specificity is not sufficient for application of the exontrapping system to large-scale screening of uncharacterized DNA fragments.
The step to identify and isolate transcribed sequences still remains a crucial technical problem. As the exon-trapping systems depend only on the structure of the introns, the sequences of the trapping cassette have significant importance. We screened the GenBank data base to find the best sequence for the trapping cassette. As the sequences of the branch sites and the polypyrimidine tract of the inserted DNA have a wide variety, the sequence of the 5' splice site should be best for the recognition of 5' splice site (27) . We chose intron 10 of the p53 gene according to the above requirements and have constructed a pMHC2 vector. This vector worked efficiently, and the sensitivity and specificity of the SETS have become sufficient to screen a large DNA fragment. We demonstrated the successful isolation of possible exons from >300-kbp DNA fragments. This indicates that YAC clones can become direct starting materials of SETS. Potential application of our system to YAC may provide a powerful tool to surmount the difficulty of cloning genes from a given DNA fragment.
Some limitations in the exon-trapping system still need to be improved. First, there are transcripts without introns. Transcribed sequences that do not undergo RNA splicing are not isolated by this system. Second, some types ofexons may not be processed in the way we expected. In other words, some exons in the target genomic DNA would be eliminated by splicing. A third limitation is the production of falsepositive exons due to activation of cryptic splice sites, although this is not a major problem, because, first, at least four fragments out of seven possible exons identified by SETS were actually present as transcripts by RNA blot analysis or RNase protection assay. Further characterization is required to determine whether the other three fragments are true exons or not. Notwithstanding the above limitations, the SETS is worthy of note.
We applied this exon-trapping system to the 11q13 region.
DNA amplification of this region has been reported in a number of human cancers. We previously reported coampli- (32, 33) . The second is the presence of yet-tobe-characterized transcribed sequences (EXPI) that map telomeric of PRADI (unpublished data). Furthermore, by using the exon-trapping system, we have isolated three transcribed sequences from the region between PRADI and HSTJ.
Most transcripts undergo RNA processing, and genomic DNA fragments are prepared by partial digestion with Sau3AI in our SETS; accordingly, exons with flanking introns will be inserted into the pMHC2 vector in the sense orientation frequently enough. Sequence analysis proved that every cloned fragment had undergone RNA splicing precisely. As demonstrated in the above results, the SETS attains sufficient sensitivity and specificity to screen genomic DNA segments of several hundred kilobase pairs by a single transfection, which implies that YACs can also be analyzed without further subcloning into cosmid vectors.
If this system is applied to the region where detailed genetic or physical maps have been constructed, the large genomic DNA segments will be effectively and easily screened for transcribed sequences. Possible application of the SETS to the regions saturated with YAC clones may allow reverse genetics to make rapid progress. A breakthrough in reverse genetics would be a great help in identifying and isolating genes responsible for human cancers and human genetic disorders.
